BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Erdoğan MA, Taşkıran E, Yiğittürk G, Erbaş O, Taşkıran D. The investigation of therapeutic potential of oxytocin and liraglutide on vincristine-induced neuropathy in rats. J Biochem Mol Toxicol 2020;34:e22415. [PMID: 31682045 DOI: 10.1002/jbt.22415] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Khodaei M, Mehri S, Pour SR, Mahdavi S, Yarmohammadi F, Hayes AW, Karimi G. The protective effect of chemical and natural compounds against vincristine-induced peripheral neuropathy (VIPN). Naunyn Schmiedebergs Arch Pharmacol 2022. [PMID: 35562512 DOI: 10.1007/s00210-022-02254-y] [Reference Citation Analysis]
2 Herradón E, González C, González A, Uranga JA, López-Miranda V. Cardiovascular Toxicity Induced by Chronic Vincristine Treatment. Front Pharmacol 2021;12:692970. [PMID: 34366848 DOI: 10.3389/fphar.2021.692970] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Zhu J, Li Y, Liang J, Li J, Huang K, Li J, Liu C. The neuroprotective effect of oxytocin on vincristine-induced neurotoxicity in mice. Toxicol Lett 2021;340:67-76. [PMID: 33429010 DOI: 10.1016/j.toxlet.2021.01.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Geisler S. Vincristine- and bortezomib-induced neuropathies - from bedside to bench and back. Exp Neurol 2021;336:113519. [PMID: 33129841 DOI: 10.1016/j.expneurol.2020.113519] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]